Ji Eun Park
New Generation University College
17 Papers
41 Citations
Ji Eun Park is an academic researcher from New Generation University College. The author has contributed to research in topics: Cisplatin & Cancer. The author has an hindex of 7, co-authored 16 publications.
Chat about Author
Papers
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
Hyerim Ha,Ah-Rong Nam,Ju-Hee Bang,Ji Eun Park,Tae Yong Kim,Kyung-Hun Lee,Kyung-Hun Lee,Sae-Won Han,Sae-Won Han,Seock-Ah Im,Seock-Ah Im,Tae-You Kim,Tae-You Kim,Yung-Jue Bang,Yung-Jue Bang,Do-Youn Oh,Do-Youn Oh +16 more
TL;DR: Serum sPDL1 can be measured and has significant role on the prognosis of advanced BTC patients treated with palliative chemotherapy and in multivariate analysis, high s PDL1 and NLR were independent poor prognostic factors.
Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
TL;DR: Bosutinib showed more potent antitumor effects in Src-activated HR cell lines than parental cell lines, and Src inhibition may be an effective measure to overcome trastuzumab resistance in HER2-positive cancer.
The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
TL;DR: In this paper, the authors measured serum soluble TGF-β (sTGFβ) levels and evaluated its dynamics and prognostic capabilities during chemotherapy in unresectable pancreatic cancer patients.
15
Psychological Distress as a Negative Survival Factor for Patients with Hematologic Malignancies Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Ji Eun Park,Kyung Im Kim,Sung-Soo Yoon,Bong Jin Hahm,Sang Min Lee,Jeong Hyun Yoon,Wan Gyoon Shin,Hye Suk Lee,Jung Mi Oh +8 more
TL;DR: To evaluate the influence of distress on overall survival of patients with hematologic malignancies who underwent allogeneic stem cell transplantation and to analyze the possible risk factors for death.
13
Src as a Therapeutic Target in Biliary Tract Cancer
Ah Rong Nam,Ji Won Kim,Ji Eun Park,Ju Hee Bang,Mei Hua Jin,Kyung Hun Lee,Tae Yong Kim,Sae-Won Han,Seock-Ah Im,Tae-You Kim,Do Youn Oh,Do Youn Oh,Yung-Jue Bang +12 more
TL;DR: Bosutinib demonstrated promising antitumor activity alone or in combination with gemcitabine or cisplatin in BTC cells, which supports further clinical development in patients with advanced BTC and suggests that Src might be a potential therapeutic target in BTC.
12